IL6 and lung carcinoma: For example, Grivennikov and Karin reported that autocrine IL-6 as an important activator of oncogenic STAT3 was implicated in lung adenocarcinomas [15]; furthermore, SOCS3 has been found to be suppressed by hypermethylation in lung cancer cells, which promoted the progression of lung cancer [16].